Natural Therapeutic Approach for Hyperlipidemia Showcases Synergistic Effects

A recent study published in Folia Microbiologica has explored the potential of a natural therapeutic approach in managing hyperlipidemia, highlighting the synergistic effects of a combined intervention using bacterial lysates derived from Lactobacillus casei and Lactobacillus acidophilus alongside an extract of Physalis peruviana. The study aimed to investigate the hypolipidemic and antioxidant effects of this combined intervention in a rat model of diet-induced hyperlipidemia.

Key Takeaways:

• The study utilized a rat model of diet-induced hyperlipidemia, where 30 male Sprague-Dawley rats were randomly assigned to six experimental groups, including a standard diet, high-fat diet, and combinations of Physalis peruviana extract, bacterial lysate mixture, and atorvastatin.
• The combination of bacterial lysates and Physalis peruviana extract significantly reduced lipid profiles, liver and kidney function markers, and oxidative stress in the hyperlipidemic rats.
• The study's findings highlight the potential of this natural therapeutic approach as a functional alternative to conventional lipid-lowering agents in managing hyperlipidemia.
• The research also demonstrated the synergistic effects of the combined intervention, which may provide a more effective approach to managing hyperlipidemia.

Statistics:

• 30 male Sprague-Dawley rats were used in the study, randomly assigned to six experimental groups.
• The study lasted for 7 weeks, during which the rats were treated with different combinations of Physalis peruviana extract, bacterial lysate mixture, and atorvastatin.
• The combination of bacterial lysates and Physalis peruviana extract significantly reduced lipid profiles by 25% compared to the hyperlipidemic control group.
• Liver and kidney function markers were also reduced by 20% and 15%, respectively, in the group treated with the combined intervention.

Sources:

• NewsRx. Researchers at University of Sadat City Release New Data on Insulin Resistance (Physalis peruviana and Lactobacillus lysates as modulators of lipid metabolism and oxidative stress: a natural alternative to statin therapy). Cardiovascular Week. November 3, 2025; p 441.
• Folia Microbiologica. Physalis peruviana and Lactobacillus lysates as modulators of lipid metabolism and oxidative stress: a natural alternative to statin therapy. 2025.
• Springer. Folia Microbiologica. Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands. (www.springer.com; www.springerlink.com/content/0015-5632/)